Prospective study for evaluating feasibily and utility of comprehensive genomic profiling test before initial systemic treatment in advanced malignant solid tumor patients
Not Applicable
- Conditions
- Advanced or recurrent solid cancer (non-small cell lung cancer, breast cancer, gastric cancer, colorectal cancer, pancreatic cancer, or biliary tract cancer)
- Registration Number
- JPRN-UMIN000040743
- Lead Sponsor
- ational Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients treated with matched targeted therapy based on the results of NCC oncopnel test (actionable gene alterations).
- Secondary Outcome Measures
Name Time Method